OBJECTIVES: To evaluate angiographic results Daporinad mouse of the cobalt chromium Vision and Mini-Vision stems (Abbott Vascular, USA).
METHODS: A total of 247 consecutive patients with 293 de novo lesions in native coronary
arteries were treated with cobalt chromium Vision (n=184; stent diameter 2.75 mm to 4.0 mm) or Mini-Vision stents (n=109; stent diameter 2.0 mm to 2.5 mm), and scheduled for six months of angiographic follow-tip. The primary end point was in-scent late loss after six months.
RESULTS: Acute coronary syndromes were present in 83.4% (n=206) of patients. The preinterventional reference diameter of Vision stents was 2.70 +/- 0.34 mm and for Mini-Vision stents, it was 2.13 +/- 0.27 mm (P<0.001). Clinical and angiographic follow-up was 98.0% and 51.2%, respectively. In the Vision group, in-scent late loss was 0.64 +/- 0.67 mm and the binary restenosis rate was 17.9%. In the Mini-Vision group, in-scent late loss wits 0.82 +/- 0.71 mm and the restenosis rate was 45.4%. No difference in occurrence of restenosis within the segments proximal or distal to the stent was observed. The restenotic pattern was predominantly focal with a short length of 7.9 +/- 4.4 mm.
CONCLUSIONS: The use of the cobalt chromium Vision stent for the
treatment of de novo lesions was associated with a low late loss and binary angiographic restenosis rate.”
“Purpose: The purpose of this study I-BET-762 was to evaluate the psychosocial support needs of teenage young adult cancer patients undergoing radiotherapy in Wales.
Method: A focus group interview was utilised to encourage dialogue and collect rich data. Transcripts were analysed through open coding and content analysis. Emergent themes in terms of psychosocial tensions were identified and categorised as external stressors and intrinsic anxieties.
Findings:
All participants indicated a desire to maintain their identity as individuals and resume as normal a life as possible throughout the treatment process and beyond. Peer support was deemed as vital to achieving this goal. Participants AZD2811 demonstrated a distinct sense of unity and group cohesion throughout the session with suggestions that they considered themselves to be very different from what they thought of as ‘usual cancer patients’. A range of information was offered prior to radiotherapy however there was variation in the efficacy of this provision between centres. At variance with literature, issues related to body image were not overtly demonstrated as significant. Support services provided by external organisations were not being signposted.
Conclusion: Psychosocial support is vital to the psychological recovery and wellbeing of young adult cancer patients. Findings suggest that issues related to peer support and age appropriate services and information are not being addressed within current service provision.